Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents smallpox and monkeypox. Lederman also discussed the company's recent financing, and its PTSD program clinical results.
Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical milestones
Quick facts: Tonix Pharmaceuticals
Price: 0.71 USD
Market Cap: $35.04 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Tonix Pharmaceuticals named herein, including the promotion by the Company of Tonix Pharmaceuticals in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE